Work

A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer

Year: 2003

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(03)00491-8

Authors: J.S Rader, D Clarke-Pearson, M Moore, L Carson, R Holloway, M.-S Kao, I Wiznitzer, E.C Douglass

Institutions: Washington University in St. Louis, Duke University, Duke Medical Center, Georgia Cancer Specialists, University of Minnesota, Walt Disney (United States), Saint Louis University, AstraZeneca (United Kingdom)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2085962358

FWCI: 1.838

Cites: 31

Cited by: 11

Related to: 10